| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |